Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cannazo India is an Ayurvedic medical cannabis and plant-based healthcare company based in Mumbai, India. Founded in 2020, the company integrates ancient Ayurvedic wisdom with modern biotechnology to develop precise, science-backed formulations designed to support physical, mental, and neurological well-being. Operating under Aglowsciences Marketing LLP and licensed by the AYUSH Department of the Government of India, Cannazo India offers a diverse portfolio of over 30 approved formulations, including CBD oils, Ayurvedic Vijaya (cannabis) extracts, topicals, and hemp nutrition products. The company utilizes advanced nanotechnology to enhance the bioavailability and absorption of cannabinoids and herbal extracts, targeting conditions such as chronic pain, anxiety, insomnia, depression, and chemotherapy-induced symptoms.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cannazo India.